Oxford BioMedica plc (GB:OXB)
LSE:OXB
OXB Analyst Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
OXB Stock 12 Month Forecast
Average Price Target
920.50 p
▲(60.09% Upside)
| Highest Price Target1,170 p | Average Price Target920.50 p | Lowest Price Target735.00 p |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
RBC Capital
1,170 p
Buy
103.48%
Upside
Reiterated
03/24/26
Jefferies
827 p
Buy
43.83%
Upside
Reiterated
03/23/26
Stifel Nicolaus
950 p
Buy
65.22%
Upside
Reiterated
03/11/26
Deutsche Bank
380 p→735 p
Buy
27.83%
Upside
Upgraded
01/06/26
J.P. Morgan
400 p→550 p
Hold
-4.35%
Downside
Reiterated
12/08/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
RBC Capital
1,170 p
Buy
103.48%
Upside
Reiterated
03/24/26
Jefferies
827 p
Buy
43.83%
Upside
Reiterated
03/23/26
Stifel Nicolaus
950 p
Buy
65.22%
Upside
Reiterated
03/11/26
Deutsche Bank
380 p→735 p
Buy
27.83%
Upside
Upgraded
01/06/26
J.P. Morgan
400 p→550 p
Hold
-4.35%
Downside
Reiterated
12/08/25
Best Analysts Covering Oxford BioMedica
3 Months
xxx
Success Rate
5/8 ratings generated profit
Average Return
+19.69%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +19.69% per trade.
1 Year
Success Rate
7/8 ratings generated profit
Average Return
+62.85%
reiterated a buy rating 26 days ago
Copying James Orsborne's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +62.85% per trade.
2 Years
xxx
Success Rate
7/8 ratings generated profit
Average Return
+84.39%
reiterated a xxx
rating 26 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 87.50% of your transactions generating a profit, with an average return of +84.39% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
OXB Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
3
4
2
3
4
Buy
1
0
0
0
1
Hold
12
13
10
9
11
Sell
2
2
6
4
7
Strong Sell
0
0
0
0
0
total
18
19
18
16
23
Each month's total comprises the sum of three months' worth of ratings.
OXB Financial Forecast
OXB Stock Forecast FAQ
What is GB:OXB’s average 12-month price target, according to analysts?
Based on analyst ratings, Oxford BioMedica plc’s 12-month average price target is 920.50.
What is GB:OXB’s upside potential, based on the analysts’ average price target?
Oxford BioMedica plc has 60.09% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Oxford BioMedica plc a Buy, Sell or Hold?
Oxford BioMedica plc has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Oxford BioMedica plc’s share price target?
The average share price target for Oxford BioMedica plc is 920.50. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is 1,170.00 p ,and the lowest forecast is 735.00 p. The average share price target represents 60.09% Increase from the current price of 575 p.
The highest analyst share price target is 1,170.00 p ,and the lowest forecast is 735.00 p. The average share price target represents 60.09% Increase from the current price of 575 p.
What do analysts say about Oxford BioMedica plc?
Oxford BioMedica plc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of Oxford BioMedica plc?
To buy shares of GB:OXB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.